CY1111404T1 - Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου - Google Patents

Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου

Info

Publication number
CY1111404T1
CY1111404T1 CY20111100409T CY111100409T CY1111404T1 CY 1111404 T1 CY1111404 T1 CY 1111404T1 CY 20111100409 T CY20111100409 T CY 20111100409T CY 111100409 T CY111100409 T CY 111100409T CY 1111404 T1 CY1111404 T1 CY 1111404T1
Authority
CY
Cyprus
Prior art keywords
compositions containing
derivatives
compositions
antibiotic compositions
eye therapy
Prior art date
Application number
CY20111100409T
Other languages
English (en)
Inventor
Gerald Cagle
Robert L Abshire
David W Stromann
John M Yanni
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1111404(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of CY1111404T1 publication Critical patent/CY1111404T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Αποκαλύπτονται οφθαλμολογικές, ωτιαίες και ρινικές συνθέσεις περιέχοντας μία νέα κατηγορία αντιβιοτικών (π.χ. μοξιφλοξασίνη). Οι συνθέσεις περιέχουν ακόμα κατά προτίμηση ένα ή περισσότερους αντιφλεγμονώδεις παράγοντες. Οι συνθέσεις μπορούν να χρησιμοποιηθούν για να θεραπεύσουν οφθαλμολογικές, ωτιαίες και ρινικές παθήσεις με τη τοπική εφαρμογή των συνθέσεων στους νοσούντες ιστούς.
CY20111100409T 1998-09-30 2011-04-21 Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου CY1111404T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10250498P 1998-09-30 1998-09-30
US10250698P 1998-09-30 1998-09-30
EP03020587A EP1384478B1 (en) 1998-09-30 1999-09-29 Antibiotic compositions containing moxifloxacin for treatment of the eye

Publications (1)

Publication Number Publication Date
CY1111404T1 true CY1111404T1 (el) 2015-08-05

Family

ID=26799441

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20111100409T CY1111404T1 (el) 1998-09-30 2011-04-21 Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου
CY20141100819T CY1115759T1 (el) 1998-09-30 2014-10-09 Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου
CY20151100023T CY1115916T1 (el) 1998-09-30 2015-01-09 Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου

Family Applications After (2)

Application Number Title Priority Date Filing Date
CY20141100819T CY1115759T1 (el) 1998-09-30 2014-10-09 Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου
CY20151100023T CY1115916T1 (el) 1998-09-30 2015-01-09 Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου

Country Status (18)

Country Link
EP (5) EP2301541B1 (el)
JP (5) JP2002525317A (el)
KR (1) KR101463243B1 (el)
CN (2) CN100374114C (el)
AR (2) AR020661A1 (el)
AT (2) ATE501732T1 (el)
AU (1) AU762827B2 (el)
BR (1) BRPI9914151B1 (el)
CA (3) CA2342211C (el)
CY (3) CY1111404T1 (el)
DE (2) DE69943287D1 (el)
DK (5) DK2796138T3 (el)
ES (4) ES2526521T3 (el)
HK (4) HK1150769A1 (el)
PT (5) PT1384478E (el)
TR (2) TR200704370T2 (el)
TW (1) TWI222361B (el)
WO (1) WO2000018386A2 (el)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DK1214056T3 (da) 1999-09-24 2004-02-09 Alcon Inc Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
WO2002007704A2 (en) 2000-07-26 2002-01-31 Alcon Universal Ltd. Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
AU2002214308A1 (en) * 2000-11-16 2002-05-27 Wakamoto Pharmaceutical Co., Ltd. Antibacterial gel eye drops
WO2002049627A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
AU2002228660A1 (en) 2000-12-20 2002-07-01 Alcon, Inc Use of amidoamines to treat or prevent acanthamoeba and fungal infections
MXPA04002576A (es) 2001-09-21 2004-06-18 Alcon Inc Metodo para tratar infecciones del oido medio.
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
AU2005282571A1 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
BRPI0518891A2 (pt) * 2004-12-10 2008-12-16 Alcon Inc composiÇço farmacÊutica àptica tàpica
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
TWI495469B (zh) * 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
AU2010266120B2 (en) * 2009-07-02 2014-02-06 Curofin Pharma Gmbh Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
CN102791270A (zh) * 2010-01-07 2012-11-21 明尼苏达大学董事会 将莫西沙星应用于耳的方法和组合物
WO2013085769A1 (en) 2011-12-06 2013-06-13 Alcon Research, Ltd. Cellulosic gel composition with improved viscosity stability
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) * 2014-09-19 2017-12-12 南京优科生物医药研究有限公司 一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
US20180311225A1 (en) * 2015-10-29 2018-11-01 Teika Pharmaceutical Co., Ltd. External preparation
JP2021524861A (ja) * 2018-04-03 2021-09-16 ハイデラバード アイ リサーチ ファウンデーション フルオロキノロン系抗生物質の眼内投与のための粘膜付着性薬物送達システム
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica
JP2023530254A (ja) * 2020-06-10 2023-07-14 オキュラー サイエンス，インク． 手術後の眼科的ケアのための組成物および方法
KR102656260B1 (ko) 2022-10-14 2024-04-09 주식회사태준제약 목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
JPH03109236A (ja) * 1989-09-22 1991-05-09 Hoya Corp 半導体超微粒子分散ガラスの製造方法
TW209865B (el) * 1992-01-10 1993-07-21 Bayer Ag
EP0639070B2 (en) 1992-05-06 2010-09-08 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) * 1994-09-22 1996-04-09 Ss Pharmaceut Co Ltd ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AU708540B2 (en) * 1995-06-06 1999-08-05 Bayer Intellectual Property Gmbh Non-irritation, nonsensitizing, non-ototoxic otic anti-bacterial compositions
JP3290914B2 (ja) * 1997-03-17 2002-06-10 参天製薬株式会社 眼組織におけるキノロン系抗菌剤の定量装置
AU731693B2 (en) * 1997-09-25 2001-04-05 Bayer Intellectual Property Gmbh Drug formulation having controlled release of active compound
HUP0103667A3 (en) 1998-09-23 2007-10-29 Unilever Nv Oral care compositions and use of metal complexes for producing of such compositions
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof

Also Published As

Publication number Publication date
CA2659064A1 (en) 2000-04-06
PT2269602E (pt) 2014-12-29
DK2301541T3 (da) 2014-09-01
HK1038691A1 (en) 2002-03-28
PT1117401E (pt) 2004-03-31
CA2342211A1 (en) 2000-04-06
EP2269602B1 (en) 2014-11-19
WO2000018386A3 (en) 2000-06-08
EP1117401B1 (en) 2003-11-19
EP2796138A1 (en) 2014-10-29
JP2013018799A (ja) 2013-01-31
CN1320035A (zh) 2001-10-31
CY1115916T1 (el) 2017-01-25
AU762827B2 (en) 2003-07-03
DE69912972T2 (de) 2004-04-22
HK1038691B (zh) 2004-04-23
JP2009007375A (ja) 2009-01-15
DK2796138T3 (en) 2016-12-05
PT2796138T (pt) 2016-09-22
AR081393A2 (es) 2012-08-29
HK1150769A1 (en) 2012-01-13
JP2012067141A (ja) 2012-04-05
CN1650863A (zh) 2005-08-10
JP2002525317A (ja) 2002-08-13
ES2602956T3 (es) 2017-02-23
CA2774207A1 (en) 2000-04-06
BRPI9914151B1 (pt) 2017-10-03
DE69912972D1 (de) 2003-12-24
EP2796138B1 (en) 2016-08-17
CN100374114C (zh) 2008-03-12
CN1184968C (zh) 2005-01-19
EP1384478A1 (en) 2004-01-28
BRPI9914151B8 (el) 2021-05-25
PT2301541E (pt) 2014-10-29
TWI222361B (en) 2004-10-21
JP2014144982A (ja) 2014-08-14
BR9914151A (pt) 2001-06-26
DK2269602T3 (en) 2014-12-15
CY1115759T1 (el) 2017-01-25
EP1117401A2 (en) 2001-07-25
ES2519190T3 (es) 2014-11-06
HK1150756A1 (en) 2012-01-13
HK1059572A1 (en) 2004-07-09
AU1310100A (en) 2000-04-17
ES2526521T3 (es) 2015-01-13
DE69943287D1 (de) 2011-04-28
JP5563041B2 (ja) 2014-07-30
KR20010075138A (ko) 2001-08-09
TR200704370T2 (tr) 2007-11-21
ATE501732T1 (de) 2011-04-15
ATE254458T1 (de) 2003-12-15
EP2269602A1 (en) 2011-01-05
TR200100883T2 (tr) 2001-10-22
ES2207307T3 (es) 2004-05-16
EP1384478B1 (en) 2011-03-16
DK1384478T3 (da) 2011-05-23
DK1117401T3 (da) 2004-02-23
KR101463243B1 (ko) 2014-12-17
CA2342211C (en) 2009-05-26
EP2301541B1 (en) 2014-08-20
WO2000018386A2 (en) 2000-04-06
EP2301541A1 (en) 2011-03-30
AR020661A1 (es) 2002-05-22
PT1384478E (pt) 2011-05-12

Similar Documents

Publication Publication Date Title
CY1111404T1 (el) Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
MX9707453A (es) Derivados de quinazolina.
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
BR9913225A (pt) Novos agentes antibacterianos de isoxazolinona
GR1000611B (el) Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης.
IT1285770B1 (it) Composti corticoidei
SE0101932D0 (sv) Pharmaceutical combinations
SE9903997D0 (sv) New compounds
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR9914158A (pt) Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
CA2339384A1 (en) Improved method for targeted topical treatment of disease
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
ES2162110T3 (es) Derivados de la quinolina antimalaria.
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.